Radiation oncology firm Accuray posted a revenue increase and lower net loss for its first quarter of fiscal 2016 (end-September 30).
For the quarter, the company's revenues were $89.6 million, a 9% increase from $82.4 million in the same period last year. In addition, the company's net loss improved, moving from $21.7 million in the first quarter of 2015 to $9.6 million for the first quarter of 2016.
The company reaffirmed that it expects its fiscal 2016 revenue to be in the range of $395 million to $410 million, a growth of 4% to 8% over fiscal 2015.
